JY
ELAN icon

Jeff Yass’s Elanco Animal Health ELAN Stock Holding History

Jeff Yass’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Sell
105,800
-137,400
-56% -$3.18M ﹤0.01% 5906
2026
Q1 		$5.82M Buy
243,200
+47,200
+24% +$1.15M ﹤0.01% 3974
2025
Q4 		$4.44M Sell
196,000
-61,500
-24% -$1.34M ﹤0.01% 4214
2025
Q3 		$5.19M Buy
257,500
+36,100
+16% +$605K ﹤0.01% 4031
2025
Q2 		$3.16M Sell
221,400
-102,200
-32% -$1.19M ﹤0.01% 4857
2025
Q1 		$3.4M Sell
323,600
-62,400
-16% -$706K ﹤0.01% 4392
2024
Q4 		$4.67M Sell
386,000
-172,700
-31% -$2.26M ﹤0.01% 3701
2024
Q3 		$8.21M Buy
558,700
+38,800
+7% +$541K ﹤0.01% 2884
2024
Q2 		$7.5M Sell
519,900
-528,400
-50% -$8.44M ﹤0.01% 2844
2024
Q1 		$17.1M Buy
1,048,300
+561,800
+115% +$8.78M ﹤0.01% 1962
2023
Q4 		$7.25M Buy
486,500
+213,900
+78% +$2.42M ﹤0.01% 3108
2023
Q3 		$3.06M Buy
272,600
+148,200
+119% +$1.72M ﹤0.01% 4343
2023
Q2 		$1.25M Buy
124,400
+8,300
+7% +$77K ﹤0.01% 6177
2023
Q1 		$1.09M Buy
116,100
+8,500
+8% +$100K ﹤0.01% 6581
2022
Q4 		$1.31M Sell
107,600
-355,000
-77% -$4.42M ﹤0.01% 5584
2022
Q3 		$5.74M Buy
462,600
+241,200
+109% +$4.22M ﹤0.01% 2945
2022
Q2 		$4.35M Sell
221,400
-45,200
-17% -$1.07M ﹤0.01% 3420
2022
Q1 		$6.96M Buy
266,600
+32,500
+14% +$866K ﹤0.01% 3097
2021
Q4 		$6.64M Sell
234,100
-116,000
-33% -$3.61M ﹤0.01% 3288
2021
Q3 		$11.2M Sell
350,100
-253,400
-42% -$8.5M ﹤0.01% 2711
2021
Q2 		$20.9M Buy
603,500
+279,700
+86% +$9.22M ﹤0.01% 1974
2021
Q1 		$9.54M Sell
323,800
-112,500
-26% -$3.46M ﹤0.01% 2843
2020
Q4 		$13.4M Buy
436,300
+142,100
+48% +$4.34M ﹤0.01% 2156
2020
Q3 		$8.22M Sell
294,200
-167,100
-36% -$4.23M ﹤0.01% 2423
2020
Q2 		$9.89M Buy
461,300
+4,600
+1% +$102K ﹤0.01% 2146
2020
Q1 		$10.2M Buy
456,700
+130,800
+40% +$3.58M ﹤0.01% 1720
2019
Q4 		$9.6M Buy
325,900
+27,900
+9% +$758K ﹤0.01% 2124
2019
Q3 		$7.92M Buy
298,000
+28,900
+11% +$867K ﹤0.01% 2216
2019
Q2 		$9.1M Sell
269,100
-98,200
-27% -$3.19M ﹤0.01% 1983
2019
Q1 		$11.8M Buy
+367,300
New +$11.3M ﹤0.01% 1589

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Jeff Yass's ELAN Position: Q2 2026 in Review

Jeff Yass increased its Elanco Animal Health (ELAN) stake by 76% in Q2 2026, buying an estimated $995K and bringing the position to 99,845 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6020.

Jeff Yass first reported a position in ELAN in Q4 2018 and has held it in 31 quarters since. The position peaked at $81M in Q1 2019. 518 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Jeff Yass held 99,845 shares of Elanco Animal Health worth $2.46M as of Q2 2026.
  • Jeff Yass bought 43,037 Elanco Animal Health shares in Q2 2026, an estimated $995K.
  • Elanco Animal Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6020 holding.
  • Jeff Yass first reported a position in Elanco Animal Health in Q4 2018 and has held it in 31 quarters since.
  • Jeff Yass's Elanco Animal Health position peaked at $81M in Q1 2019.
  • 518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.